Literature DB >> 20026621

Intended transcriptional silencing with siRNA results in gene repression through sequence-specific off-targeting.

Joshua Moses1, Amber Goodchild, Laurent P Rivory.   

Abstract

Transcriptional gene silencing has been reported with siRNA targeting the promoter region of genes. We tested several siRNAs directed against the human VEGF promoter. Of these, siVFp(-992) exhibited > or =50% suppression of VEGF production in two human cell lines. To determine the specificity of this siRNA-mediated suppression, plasmids were prepared to express a luciferase reporter under the control of VEGF promoters featuring wild-type, mutated, or deleted target sequences. siRNA transfection assays established sequence-specific inhibition of luciferase from the reporter plasmid featuring the wild-type VEGF promoter. However, siVFp(-992) also suppressed the luciferase expression from the plasmids with mutated or deleted target sites, suggesting that silencing was due to a sequence-specific off-target phenomenon, and this was supported by subsequent microarray and bioinformatics analyses. To determine if our concerns regarding the specificity of promoter targeting siRNAs were relevant to other systems where RNA-mediated transcriptional silencing had been previously reported, we tested a published small RNA sequence directed to the HIV(SF2)-LTR promoter. siRNA transfection assays performed in human cells expressing a luciferase reporter gene under the control of the HIV(SF2)-LTR promoter revealed significant suppression whether the target sequence was intact or mutated, or when the entire HIV(SF2)-LTR was replaced by an irrelevant promoter. These data stress the need to examine target specificity when conducting investigations into transcriptional gene regulation with siRNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026621      PMCID: PMC2811671          DOI: 10.1261/rna.1808510

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  41 in total

Review 1.  Met receptor tyrosine kinase: enhanced signaling through adapter proteins.

Authors:  K A Furge; Y W Zhang; G F Vande Woude
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

2.  Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.

Authors:  S M Elbashir; J Martinez; A Patkaniowska; W Lendeckel; T Tuschl
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Whither RNAi?

Authors: 
Journal:  Nat Cell Biol       Date:  2003-06       Impact factor: 28.824

4.  Expression profiling reveals off-target gene regulation by RNAi.

Authors:  Aimee L Jackson; Steven R Bartz; Janell Schelter; Sumire V Kobayashi; Julja Burchard; Mao Mao; Bin Li; Guy Cavet; Peter S Linsley
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

5.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

6.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.

Authors:  Stéphanie Filleur; Aurélie Courtin; Slimane Ait-Si-Ali; Julien Guglielmi; Carole Merle; Annick Harel-Bellan; Philippe Clézardin; Florence Cabon
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery.

Authors:  Manika Pal-Bhadra; Boris A Leibovitch; Sumit G Gandhi; Madhusudana Rao Chikka; Madhusudana Rao; Utpal Bhadra; James A Birchler; Sarah C R Elgin
Journal:  Science       Date:  2004-01-30       Impact factor: 47.728

10.  Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi.

Authors:  Thomas A Volpe; Catherine Kidner; Ira M Hall; Grace Teng; Shiv I S Grewal; Robert A Martienssen
Journal:  Science       Date:  2002-08-22       Impact factor: 47.728

View more
  10 in total

1.  Characterization of an HIV-targeted transcriptional gene-silencing RNA in primary cells.

Authors:  Anne-Marie W Turner; Amanda M Ackley; Michael A Matrone; Kevin V Morris
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.

Authors:  Kazuo Suzuki; Takaomi Ishida; Makoto Yamagishi; Chantelle Ahlenstiel; Sanjay Swaminathan; Katharine Marks; Daniel Murray; Erin M McCartney; Michael R Beard; Marina Alexander; Damian F J Purcell; David A Cooper; Toshiki Watanabe; Anthony D Kelleher
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

Review 3.  RNAi and small interfering RNAs in human disease therapeutic applications.

Authors:  Monica R Lares; John J Rossi; Dominique L Ouellet
Journal:  Trends Biotechnol       Date:  2010-09-15       Impact factor: 19.536

4.  dsRNA expression in the mouse elicits RNAi in oocytes and low adenosine deamination in somatic cells.

Authors:  Jana Nejepinska; Radek Malik; Jody Filkowski; Matyas Flemr; Witold Filipowicz; Petr Svoboda
Journal:  Nucleic Acids Res       Date:  2011-09-08       Impact factor: 16.971

5.  E-cadherin is transcriptionally activated via suppression of ZEB1 transcriptional repressor by small RNA-mediated gene silencing.

Authors:  Minami Mazda; Kenji Nishi; Yuki Naito; Kumiko Ui-Tei
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

6.  Optimizations of siRNA design for the activation of gene transcription by targeting the TATA-box motif.

Authors:  Miaomiao Fan; Yijun Zhang; Zhuoqiong Huang; Jun Liu; Xuemin Guo; Hui Zhang; Haihua Luo
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

Review 7.  The varied roles of nuclear argonaute-small RNA complexes and avenues for therapy.

Authors:  Jason P Ross; Zena Kassir
Journal:  Mol Ther Nucleic Acids       Date:  2014-10-14       Impact factor: 10.183

8.  Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.

Authors:  Marc Suñé-Pou; Silvia Prieto-Sánchez; Younes El Yousfi; Sofía Boyero-Corral; Anna Nardi-Ricart; Isaac Nofrerias-Roig; Pilar Pérez-Lozano; Encarna García-Montoya; Montserrat Miñarro-Carmona; Josep Ramón Ticó; Josep Mª Suñé-Negre; Cristina Hernández-Munain; Carlos Suñé
Journal:  Int J Nanomedicine       Date:  2018-05-30

Review 9.  Regulation of mammalian transcription and splicing by Nuclear RNAi.

Authors:  Roya Kalantari; Cheng-Ming Chiang; David R Corey
Journal:  Nucleic Acids Res       Date:  2015-11-26       Impact factor: 16.971

10.  Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing.

Authors:  Chantelle Ahlenstiel; Catalina Mendez; Steven T H Lim; Katherine Marks; Stuart Turville; David A Cooper; Anthony D Kelleher; Kazuo Suzuki
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-27       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.